G.T.A.R.A.: Grip/Grasp Training with Active Range of Motion Activities using Guitar
UP Diliman
Re-emerging and Emerging Diseases (RED)
Ongoing Projects
Aptamer-Based Multiplex Assay for the Early Detection of Leptospirosis
UP Diliman
Diagnostics
Enteric Solutions: Development of a Vertical Flow Microarray (VFM) for the Detection of Enteric Viruses
UP Diliman
Diagnostics
Development of Novel Detection Tools for the Integrated Surveillance and Monitoring of Helminthic Neglected Tropical Diseases (NTDs) of Mutual Public Health Importance in the Philippines and China
UP Diliman
Diagnostics
The UK-Philippines Remote Retinal Evaluation Collaboration in Health: Diabetic Retinopathy (REACH-DR)
UP Manila
Omics for Health
Cellular immunity and resistance to schistosomiasis in the Philippines (Newton Agham Cycle 2)
RITM
Omics for Health
ZooTRIP: Zoonotic transmission of intestinal parasites: implications for control and elimination (Newton Agham Cycle 2)
UP Los Baños
Omics for Health
Using Tuberculosis host-pathogen genetic interactions to improve diagnostics in the Philippines (Newton Agham Cycle 2)
RITM
Omics for Health
SPEEDIER – Surveillance integrating Phylogenetics and Epidemiology for Elimination of Disease: Evaluation of Rabies Control in the Philippines (Newton Agham Cycle 2)
Field Epidemiology Training Program Alumni Foundation, Inc. (FETPAFI)
Omics for Health
Affordable near-patient diagnostics to distinguish infectious diseases in the Philippines (AND2ID in Ph) (Newton Agham Cycle 2)
University of Santo Tomas
Omics for Health
Clinical Proteomics for Cancer Initiative: A Proteomics-Based Discovery of Non-Small Cell Lung Cancer Biomarkers and Drug Targets in the Philippines: Project 3: Proteomic analysis of aberrant protein expression in Non-Small Cell Lung Cancer (NSCLC)
UP Diliman
Omics for Health
Clinical Proteomics for Cancer Initiative: A Proteomics-Based Discovery of Non-Small Cell Lung Cancer Biomarkers and Drug Targets in the Philippines: Project 2: Sample Processing for Proteomic Analysis and Functional Characterization and Early Clinical Confirmation of Biomarker Application
UP Diliman
Omics for Health
Clinical Proteomics for Cancer Initiative: A Proteomics-Based Discovery of Non-Small Cell Lung Cancer Biomarkers and Drug Targets in the Philippines: Project 1: Assembly and Archiving of Clinical Samples for Proteomic Analysis
Lung Center of the Philippines
Omics for Health
Establishment of Genomics Consortium and Core Facility in Visayas
UP Visayas
Omics for Health
Establishment of Genomics Consortium and Core Facility in Mindanao
UP Mindanao
Omics for Health
Installation and Operation of the Philippine Genome Center -Protein Proteomics, and Metabolomics Facility (PPMF)
UP Diliman
Omics for Health
Project 1: Establishing a Clinical and Genomic Profile of Filipinos for Early Detection of Liver Cancer
UP Manila
Omics for Health
Filipino Genomes Region for to Help Resolve Child Sexual Abuse Cases
UP Diliman
Omics for Health
Filipino Genomes: History, Evolution, Origins and Applications
UP Diliman
Omics for Health
Filipino Forensic Genomics (Phase I)
UP Diliman
Omics for Health
Evaluation of the Safety and Feasibility of Intramuscular Transplantation of Umbilical cord- derived Mesenchymal Stem Cells for Diabetic Foot Ulceration
Makati Medical Center
Omics for Health
Epidemiology of Acute and Severe Dengue Infection through the Integrated Analysis of Molecular, Virologic and Clinical Factors
St. Lukes Memorial Medical Center
Omics for Health
The Predict-XDR Project: Predicting Genetic Markers for Pre-XDR and XDR Tuberculosis
UP Manila
Omics for Health
Project 2. AI-driven Integration of Genomic, Ultrasound, Serum Biomarkers, and Clinical data for Early Diagnosis of Liver Cancer
UP Los Baños
Omics for Health
WAGAS: Integrated Wastewater-Based Epidemiology and Data Analytics for Community-Level Pathogen Surveillance and Genetic Tracking: Proof-of-Concept
UP Mindanao
Omics for Health
CUSOG: Vulnerability Assessment Tool: A Decision Support System for Pre-Emptive Preparedness on Emerging Infections Among Animal Reservoir in Urban Green Spaces
UP Mindanao
Omics for Health
RESILIEMC: Risk Management and Enhanced Survival Analysis Integrated through Longitudinal Infectious Disease Data and Statistical Epidemiological Model using Clinical Risk Factors
Malayan Colleges Mindanao
Omics for Health
PPASTOL: Predictive Modeling and Viral Phylodynamic Analysis on the Spatial and Temporal Patterns of Disease Outbreaks with considerations for Control and Logistics applied in Mindanao region
UP Mindanao
Omics for Health
The Philippine Virome Database Project
Philippine Genome Center
Omics for Health
Development of Breast Cancer Mammosphere Assay for Chemotherapy Screening
UP Diliman
Omics for Health
Next Generation Sequencing -based expression profiling of Breast Cancer among Filipinos and Prediction of Response to Neoadjuvant Therapy for Locoregionally-Advanced Breast Cancer in Filipinos
UP Manila
Omics for Health
Development of HIV Disease Models and in vitro Investigation of HIV-related Neurocognitive and Metabolic Complications
UP Diliman
Omics for Health
Biomarkers of Immune Dysfunction in HIV – associated Metabolic and Neurocognitive Complications
UP Manila
Omics for Health
Discovery and Development of Health Products: Disease-Specific Bioactive Hits from Terrestrial Organisms: Confirmatory and Orthogonal Assays to Eliminate Artefactual Drug Bioactivities (Phase 3): Continuing Needs of the Tuklas Lunas Program
UP Diliman
Tuklas Lunas
Philippine Biorepository Network: Development of Biobanking Facility for Plant Extracts/Compounds for Drug Discovery
UP Diliman
Tuklas Lunas
DDHP: Marine Component Phase 2: Project 2. Anti-Infective and Anti-Cancer Drug Candidates from Marine Microorganisms and Sponges: Discovery and Development
UP Diliman
Tuklas Lunas
DDHP: Marine Component Phase 2: Project 1. Anti-Pain and Anti-Neurodegeneration Drug Candidates: Discovery and Development
UP Diliman
Tuklas Lunas
Bridging Efficacy and Safey: IND-enabling Suite of ADMETox Assays: Project 3. HPLC and Mass Spectral Studies to Support Various ADMET assays
UP Diliman
Tuklas Lunas
Bridging Efficacy and Safey: IND-enabling Suite of ADMETox Assays: Project 2. Cell-based ADMET assays
UP Diliman
Tuklas Lunas
Bridging Efficacy and Safey: IND-enabling Suite of ADMETox Assays Project 1. Optimization of Physico-Chemical Drug Properties
UP Diliman
Tuklas Lunas
Synthesis and Derivatization of Disease-specific Bioactive Hits and Lead Compounds (Phase II) Project 6. Computer-Aided Drug Design of Natural Products-Based, and Synthetic Antidiabetic, Antifungal, and Anticancer Lead Compounds and Derivatives
UP Diliman
Tuklas Lunas
Synthesis and Derivatization of Disease-specific Bioactive Hits and Lead Compounds (Phase II): Project 3. Synthesis of Deguelin, Rotenone, and Small Molecule Derivatives as Anticancer Agents
UP Diliman
Tuklas Lunas
Synthesis and Derivatization of Disease-specific Bioactive Hits and Lead Compounds (Phase II): Project 2. Molecular Docking and ADME-Tox–guided Synthesis of Azole-Based Anti-Infective Agents
UP Diliman
Tuklas Lunas
Synthesis and Derivatization of Disease-specific Bioactive Hits and Lead Compounds (Phase II): Project 1. Lead Optimization, In Silico Prediction, Molecular Docking and Determination of ADMETox Properties of Small Molecules as Antidiabetic Drugs
UP Diliman
Tuklas Lunas
Discovery and Development of Health Products (DDHP): Disease-Specific Bioactive Hits from Terrestrial Organisms Project 11. De-replication with LC-MS Based Metabolomics
UP Diliman
Tuklas Lunas
Technical Battle Against COVID: Project 2. Rational Design and Structural Modifications of ACE2 Inhibitors from Terrestrial Plants
UP Diliman
Covid-19
Technical Battle Against COVID: Project 1. Design and Synthesis of SARS-COV2, ACE2, SARS- COV2:ACE2 Destabilizing Compounds
UP Diliman
Covid-19
CRISPR-based Diagnostics (CRISPR-Dx) for the detection of SARS-CoV-2 and TB
UP Diliman
Covid-19
Compounds Active Against Cancer Lines (HCT116, MCF7, A549) from Priority Extracts – Phase II
UP Diliman
Tuklas Lunas
Discovery and Development of Health Products [DDHP]: Formulation, Standardization, and Metabolic Profiling of Disease-Specific Top-Tier Plants for Pre-Clinical and Clinical Development Project 3. Standardized Dosage Forms of Biologically Active Extracts Suitable for Use in Pre-clinical and Clinical Research: Top Tier Herbs for Cancer
UP Diliman
Tuklas Lunas
Structure Identification of Anti-inflammatory and Anti-Pain Agents from Priority Extracts (Phase 4)
UP Diliman
Tuklas Lunas
Anti-inflammatory and Anti-diabetic compounds from top-tier bioactive extracts
UP Diliman
Tuklas Lunas
Establishing an Antibody Neutralization Assay for Characterization and Immunosurveillance of Emerging SARS-COV-2 Variants of Concern
UP Diliman
Covid-19
